Document is current
Any future updates will be listed below
-
Authors
Corcorran, Maria A.
Thornton, Karla
Struminger, Bruce
Easterbrook, Philippa
Scott, John D.
-
Funding
Funding for this research was provided by:
World Health Organization
National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK007742-22)
National Institute of Allergy and Infectious Diseases (5T32AI007044-43)
- License Information
-
More Information
Article History
Received: 19 January 2023
Accepted: 26 July 2023
First Online: 2 August 2023
Declarations
:
: All study activities were conducted in accordance with the Declaration of Helsinki, and participants provided verbal consent for participation. Guidance provided by the University of Washington Human Subjectes Division determined that this work did not involve human subjects and therefore did not require formal IRB review and approval, as data was collected on ECHO programmes and not individuals as part of a descriptive program evaluation project.
: Not applicable.
: J.S. has done consulting work for Guidepoint and has served on the following committees: (1) Advisory board for Veklury, Gilead Sciences (2021); (2) Data adjudication committee for Novo Nordisk; (3) Pharmacy and Therapeutics committee for Premera Blue Cross. All other authors declare they have no competing interests.
